z-logo
open-access-imgOpen Access
Evaluation of Moxalactam with the BD Phoenix System for Detection of Methicillin Resistance in Coagulase-Negative Staphylococci
Author(s) -
H. Pupin,
H. Renaudin,
Olivier JoinLambert,
Cécile Bébéar,
Françis Mégraud,
Philippe Lehours
Publication year - 2007
Publication title -
journal of clinical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.349
H-Index - 255
eISSN - 1070-633X
pISSN - 0095-1137
DOI - 10.1128/jcm.00578-07
Subject(s) - moxalactam , cefoxitin , coagulase , microbiology and biotechnology , staphylococcus saprophyticus , latamoxef , staphylococcus , micrococcaceae , medicine , antibacterial agent , biology , staphylococcus aureus , antibiotics , cephalosporin , bacteria , genetics
The performance of moxalactam with the BD Phoenix system for the detection of methicillin resistance in coagulase-negative staphylococci was evaluated by use of a collection of 186 strains. Moxalactam was a better drug as an indicator of methicillin resistance formecA -positive strains than oxacillin and cefoxitin were. For strains other thanStaphylococcus saprophyticus , a moxalactam MIC >16 μg/ml was indicative of methicillin resistance.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom